Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorporation (CONITEC). However, these medicines were dis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rev Inst Med Trop Sao Paulo
Hlavní autoři: Gomes, Lenyta Oliveira, Teixeira, Marina Rodrigues, da Rosa, Júnior André, Feltrin, Alberi Adolfo, Rodrigues, João Paulo V., Vecchi, Mariane D’Avila, Carneiro, Jane Meire M., Noblat, Lúcia de Araújo C. B., Chachá, Silvana Gama F., Martinelli, Ana de Lourdes C., Pereira, Leonardo Regis L., Silveira, Marysabel Pinto T., Blatt, Carine Raquel, Farias, Mareni Rocha
Médium: Artigo
Jazyk:Inglês
Vydáno: Instituto de Medicina Tropical 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6029893/
https://ncbi.nlm.nih.gov/pubmed/29972466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1678-9946201860029
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky